Novartis Kisqali® NATALEE analysis reinforces consisten

Late-breaking NATALEE subgroup analysis to be presented at ESMO shows invasive disease-free survival benefit remains consistent in all subgroups, including in patients with stage II tumors,...

Related Keywords

France , Madrid , Spain , Switzerland , Texas , United States , Chicago , Illinois , Lugano , Ticino , Norway , Paris , France General , San Antonio , Barcelona , Comunidad Autonoma De Cataluna , American , America , Julie Masow , Richard Jarvis , Parag Mahanti , Imke Kappes , Aditya Bardia , Satoshi Sugimoto , Nicole Zinsli Somm , Sloan Simpson , Jonathan Graham , Samir Shah , Jeff Legos , Marlena Abdinoor , Michael Meo , Isabella Zinck , Harvard Medical School , Vestre Viken Hospital , European Society For Medical Oncology , Novartis Institutes For Biomedical Research , Akershus University Hospital , American Society Of Clinical Oncology Annual Meeting , American Cancer Society , Drug Administration , Presentation At European Society For Medical Oncology , Exchange Commission , Pfizer Inc , Astex Pharmaceuticals , Instagram , Global Head Of Oncology Development At Novartis , Facebook , European Society Of Medical Oncology Congress , Novartis , American Society Of Clinical Oncology , Cancer Center , Linkedin , European Commission , European Society , Medical Oncology , Attending Physician , Mass General Cancer Center , Associate Professor , Executive Vice President , Global Head , Oncology Development , Standardized Definitions , Efficacy End Points , American Society , Clinical Oncology , Annual Meeting , Clinical Benefit Scale , United States Food , Novartis Institutes , Biomedical Research , Prescribing Information , Clinical Oncology Annual Meeting , Virtual Plenary , Accessed October , Medical Oncology Breast Cancer , Advanced Breast , New England Journal , Medical Oncology Congress , San Antonio Breast Cancer Symposium , Practice Guidelines , Published March , Published April , Vestre Viken Hospital Trust , Neoadjuvant Treatment , Locally Advanced Breast Cancer Patients , Markets ,